MARKET

SRDX

SRDX

Surmodics Inc
NASDAQ
26.92
+1.53
+6.03%
After Hours: 26.92 0 0.00% 16:01 04/23 EDT
OPEN
25.56
PREV CLOSE
25.39
HIGH
27.00
LOW
25.35
VOLUME
52.91K
TURNOVER
0
52 WEEK HIGH
39.41
52 WEEK LOW
16.79
MARKET CAP
383.23M
P/E (TTM)
68.83
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SRDX last week (0415-0419)?
Weekly Report · 1d ago
Press Release: Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1 Earnings Conference Call and Webcast Will Begin at 7:00 am (CT) on Wednesday, May 1. Surmodics is a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry. The second quarter of fiscal year 2024 financial results will be released before the market opens. Management will host a live webcast and conference call.
Dow Jones · 4d ago
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics, Inc. Is a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry. Second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 1. Management will host a live webcast and conference call to discuss the second quarter fiscal 2024 results.
Barchart · 4d ago
Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know
NASDAQ · 6d ago
Weekly Report: what happened at SRDX last week (0408-0412)?
Weekly Report · 04/15 09:00
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Needham sees BSX, CNMD, RMD and Surmodics beating Street, despite medtech slow down. Needham estimates medtech sales grew less than expected in Q1, but that Boston Scientific, CONMED and ResMed should still beat the Street. The investment firm says medtech market only grew by 5.3% in the first quarter of 2024.
Seeking Alpha · 04/14 21:56
Analysts Offer Insights on Healthcare Companies: Genprex (GNPX) and SurModics (SRDX)
TipRanks · 04/10 14:50
Neogen (NEOG) Q3 Earnings and Revenues Lag Estimates
NASDAQ · 04/09 12:10
More
About SRDX
Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The Company's segments include Medical Device and IVD. The Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral, coronary and structural heart. It manufactures vascular intervention medical devices, including drug-coated balloons, and radial access balloon catheters and guide sheaths. The IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

Webull offers Surmodics Inc stock information, including NASDAQ: SRDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRDX stock methods without spending real money on the virtual paper trading platform.